SCHEMBL6023289

SCHEMBL6023289

COc1ccc(Cc2nc3c(nc(C)n3C(CCCc3ccccc3)C(C)=O)c(=O)[nH]2)cc1OC(F)F

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PDE2A O00408 10/20 0.47
PDE4A P27815 4/20 0.37
PDE4B Q07343 4/20 0.37
PDE4C Q08493 4/20 0.37
PDE4D Q08499 4/20 0.37
RNASEH1 O60930 1/20 0.37
CCNE2 O96020 1/20 0.36
CDK4 P11802 1/20 0.36
CCND1 P24385 1/20 0.36
CCNE1 P24864 1/20 0.36
CDK2 P24941 1/20 0.36
POLB P06746 1/20 0.36
ALDH1A1 P00352 2/20 0.36
TP53 P04637 1/20 0.36
HPGD P15428 1/20 0.36
MAPK1 P28482 1/20 0.36
KDM4E B2RXH2 1/20 0.35
ATM Q13315 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6024102 0.97 PDE2A (0.47) PDE2APDE4APDE4BPDE4CPDE4D
SCHEMBL6023972 0.89 PDE2A (0.52) PDE2APDE4APDE4BPDE4CPDE4D
SCHEMBL6024368 0.88 PDE2A (0.46) PDE2APDE4APDE4BPDE4CPDE4D
SCHEMBL6024717 0.85 PDE2A (0.46) PDE2APDE4APDE4BPDE4CPDE4D
SCHEMBL359546 0.81 PDE2A (0.51) PDE2ARNASEH1CCNE2CDK4CCND1
SCHEMBL6023491 0.79 PDE2A (0.44) PDE2APDE4APDE4BPDE4CPDE4D
SCHEMBL6023837 0.79 PDE2A (0.51) PDE2APDE4APDE4BPDE4CPDE4D
SCHEMBL6023455 0.79 PDE2A (0.43) PDE2APDE4APDE4BPDE4CPDE4D
SCHEMBL6992393 0.78 PDE2A (0.55) PDE2ARNASEH1CCNE2CDK4CCND1
SCHEMBL6024603 0.77 PDE2A (0.42) PDE2ARNASEH1CCNE2CDK4CCND1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060106037-A1 Purin-6-one-derivatives ALTANA PHARMA AG (DE) 2006-05-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060106037-A1 Purin-6-one-derivatives PDE4B, PDE4A, PDE2A PDE2A 3/4885PDE4A 2/4885PDE4B 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.